YU90102A - Jedinjenja sa sulfonamidnom grupom i farmaceutski sastavi koji sadrže ova jedinjenja - Google Patents
Jedinjenja sa sulfonamidnom grupom i farmaceutski sastavi koji sadrže ova jedinjenjaInfo
- Publication number
- YU90102A YU90102A YU90102A YUP90102A YU90102A YU 90102 A YU90102 A YU 90102A YU 90102 A YU90102 A YU 90102A YU P90102 A YUP90102 A YU P90102A YU 90102 A YU90102 A YU 90102A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- group
- erythrocytes
- compounds
- substances
- active agent
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical group NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 6
- 210000003743 erythrocyte Anatomy 0.000 abstract 6
- 230000000694 effects Effects 0.000 abstract 4
- 229940002612 prodrug Drugs 0.000 abstract 4
- 239000000651 prodrug Substances 0.000 abstract 4
- 239000000126 substance Substances 0.000 abstract 4
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 239000005445 natural material Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Pronalazak se odnosi na jedinjenja, koja dejstvujući kao prolek i/ili podrška, omogućava aktivnom sredstvu da bude absorbovano od strane eritrocita i/ili aktivno sredstvo koje se vezuje na eritrocite. Unošenje ovih jedinjenja i/ili njihovo vezivanje na eritrocite moguće je putem grupe sa formulom -SO2NR1R2, gde R1 i R2, nezavisno jedan od drugog, znače atom vodonika, acil grupa, alkil grupa, cikloalkil grupa, aril grupa, cijano grupa ili hidroksi grupa. Pronađeni prolekovi omogućavaju aktivnim sredstvima kao što su endogene supstance, prirodne supstance i sintetičke supstance sa korisnim terapeutskim osobinama koje imaju visoki efekat "prve putanje", da budu efektivno administrirane oralno ili da značajno poboljšaju njihovu oralnu aktivnost.[The invention relates to compounds which, acting as a prodrug and/or support, enable an active agent to be taken up by the erythrocytes and/or an active agent to bind to the erythrocytes. The uptake of these compounds by and/or the binding thereof to the erythrocytes is made possible by a group of formula -SO2NR1R2, wherein R1 and R2, independently of each other, mean a hydrogen atom, an acyl group, an alkyl group, a cycloalkyl group, an aryl group, a cyano group or a hydroxy group. The inventive prodrugs enable active agents such as endogenic substances, natural substances and synthetic substances with therapeutically useful properties which have a high "first path" effect, to be administered orally effectively or significantly improve the oral activity thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10027887A DE10027887A1 (de) | 2000-05-31 | 2000-05-31 | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU90102A true YU90102A (sh) | 2006-05-25 |
Family
ID=7644802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU90102A YU90102A (sh) | 2000-05-31 | 2001-05-08 | Jedinjenja sa sulfonamidnom grupom i farmaceutski sastavi koji sadrže ova jedinjenja |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US7507725B2 (sh) |
| EP (1) | EP1294402B2 (sh) |
| JP (1) | JP2003534386A (sh) |
| KR (3) | KR20080038460A (sh) |
| CN (1) | CN1441678A (sh) |
| AT (1) | ATE315407T1 (sh) |
| AU (2) | AU6593301A (sh) |
| BG (1) | BG107556A (sh) |
| BR (1) | BR0111294A (sh) |
| CA (1) | CA2410630A1 (sh) |
| CZ (1) | CZ2003621A3 (sh) |
| DE (2) | DE10027887A1 (sh) |
| DK (1) | DK1294402T4 (sh) |
| EA (1) | EA006432B1 (sh) |
| ES (1) | ES2256256T5 (sh) |
| HR (1) | HRP20021038B1 (sh) |
| HU (1) | HUP0301949A3 (sh) |
| IL (2) | IL152932A0 (sh) |
| ME (1) | MEP14608A (sh) |
| MX (1) | MXPA02011844A (sh) |
| NO (1) | NO20025739D0 (sh) |
| NZ (1) | NZ535201A (sh) |
| PL (1) | PL206462B1 (sh) |
| PT (1) | PT1294402E (sh) |
| SK (1) | SK2912003A3 (sh) |
| UA (1) | UA76953C2 (sh) |
| WO (1) | WO2001091797A2 (sh) |
| YU (1) | YU90102A (sh) |
| ZA (1) | ZA200209490B (sh) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10027887A1 (de) | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| US8026229B2 (en) | 2001-08-13 | 2011-09-27 | Sterix Limited | Antitumor-active 2-alkoxyestradiol sulfamates |
| DE102004025966A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estradiol-Prodrugs |
| US7534780B2 (en) | 2004-05-21 | 2009-05-19 | Bayer Schering Pharma Aktiengesellschaft | Estradiol prodrugs |
| US20050277625A1 (en) * | 2004-05-21 | 2005-12-15 | Ralf Wyrwa | Estriol and estetrol prodrugs |
| DE102004025985A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estriol- und Estetrol-Prodrugs |
| US20050282793A1 (en) * | 2004-05-21 | 2005-12-22 | Ralf Wyrwa | Steroid prodrugs with androgenic action |
| DE102004025986A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Steroid-Prodrugs mit androgener Wirkung |
| DE102005057224A1 (de) | 2005-11-29 | 2007-05-31 | Bayer Schering Pharma Ag | Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| DE102005057225A1 (de) * | 2005-11-29 | 2007-05-31 | Bayer Schering Pharma Ag | Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| US20070197488A1 (en) * | 2005-11-29 | 2007-08-23 | Olaf Peters | Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds |
| US20070123500A1 (en) * | 2005-11-29 | 2007-05-31 | Gerd Mueller | Prodrugs of ERbeta-selective substances, processes for their preparation and pharmaceutical compositions comprising these compounds |
| DE102005057421A1 (de) * | 2005-11-30 | 2007-05-31 | Bayer Schering Pharma Ag | Heteroaromatische Sulfonamid-Prodrugs |
| US20070135375A1 (en) * | 2005-11-30 | 2007-06-14 | Ralf Wyrwa | Sulfamoyl sulfonate prodrugs |
| US20070135399A1 (en) * | 2005-11-30 | 2007-06-14 | Ralf Wyrwa | Heteroaromatic sulphonamide prodrugs |
| DE102005057408A1 (de) * | 2005-11-30 | 2007-05-31 | Bayer Schering Pharma Ag | Sulfamoylsulfonat-Prodrugs |
| US8777182B2 (en) | 2008-05-20 | 2014-07-15 | Grinon Industries | Fluid transfer assembly and methods of fluid transfer |
| NZ604017A (en) | 2008-05-20 | 2014-03-28 | Grinon Ind | Fluid transfer assembly and methods of fluid transfer |
| US9100458B2 (en) * | 2008-09-11 | 2015-08-04 | At&T Intellectual Property I, L.P. | Apparatus and method for delivering media content |
| CN101987102A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 一种糖皮质激素杂芳香基氨磺酰基羧酸酯的眼用抗炎组合物 |
| CN101987104A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物 |
| WO2013102130A1 (en) * | 2011-12-30 | 2013-07-04 | Grinon Industries | Fluid transfer assembly and methods of fluid transfer |
| MX364743B (es) * | 2013-07-11 | 2019-05-06 | Evestra Inc | Profármacos de formación de compuestos. |
| US11571505B2 (en) | 2015-11-27 | 2023-02-07 | Sanofi-Aventis Deutschland Gmbh | Drug delivery device with a cap |
| EP3173113A1 (en) | 2015-11-27 | 2017-05-31 | Sanofi-Aventis Deutschland GmbH | An injection needle assembly |
| EP3697421B1 (en) | 2017-10-19 | 2024-04-17 | Evestra, Inc. | Longer-acting progestin prodrug contraceptives |
| EP4247793A1 (en) * | 2020-11-17 | 2023-09-27 | H. Lundbeck A/S | New catecholamine prodrugs for use in the treatment of parkinson's disease |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1203042B (de) * | 1963-11-21 | 1965-10-14 | Schering Ag | Fungizide Mittel |
| GB1593609A (en) | 1978-01-31 | 1981-07-22 | Christiaens Sa A | Pyridine sulfonamides |
| US4244940A (en) * | 1978-09-05 | 1981-01-13 | Bio-Rad Laboratories, Inc. | Single-incubation two-site immunoassay |
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| GB8327256D0 (en) * | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
| US5001234A (en) † | 1987-04-16 | 1991-03-19 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
| US4792569A (en) | 1987-08-27 | 1988-12-20 | Mcneilab, Inc. | Anticonvulsant phenethyl sulfamates |
| US5116828A (en) | 1989-10-26 | 1992-05-26 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition for treatment of osteoporosis |
| US5025031A (en) * | 1989-11-30 | 1991-06-18 | A. H. Robins Co., Inc. | Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants |
| GB9118478D0 (en) * | 1991-08-29 | 1991-10-16 | Imperial College | Steroid sulphatase inhibitors |
| DE4236237A1 (de) | 1992-10-27 | 1994-04-28 | Behringwerke Ag | Prodrugs, ihre Herstellung und Verwendung als Arzneimittel |
| US5384327A (en) | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
| IL109431A (en) | 1993-05-14 | 2001-01-11 | Warner Lambert Co | Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds |
| DE4429397C2 (de) | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| DE4447714C2 (de) | 1994-08-09 | 1998-02-05 | Jenapharm Gmbh | Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie |
| US5571933A (en) | 1994-11-17 | 1996-11-05 | Duquesne University Of The Holy Ghost | Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use |
| DE19540233B4 (de) | 1995-10-19 | 2005-08-25 | Schering Ag | Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| US5705495A (en) * | 1995-10-19 | 1998-01-06 | Jenapharm Gmbh & Co. Kg. | Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds |
| DE19712488A1 (de) | 1997-03-25 | 1998-10-01 | Knoell Hans Forschung Ev | Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben |
| DE19723794A1 (de) * | 1997-06-06 | 1998-12-10 | Jenapharm Gmbh | Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität |
| WO2000006475A1 (en) * | 1998-07-29 | 2000-02-10 | Crisplant A/S | Parcel singulation system |
| US6583130B1 (en) | 1999-09-13 | 2003-06-24 | Schering Ag | C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds |
| US6958327B1 (en) * | 1999-11-02 | 2005-10-25 | Schering, Ag | 18 Norsteroids as selectively active estrogens |
| AU2533101A (en) * | 2000-01-14 | 2001-07-24 | Schering Aktiengesellschaft | Composition |
| AU5834101A (en) | 2000-04-12 | 2001-10-23 | Schering Ag | 8ss-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| DE10027887A1 (de) | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| US6355666B1 (en) | 2000-06-23 | 2002-03-12 | Medinox, Inc. | Protected forms of pharmacologically active agents and uses therefor |
| CA2437594A1 (en) | 2001-03-02 | 2002-09-12 | Graham S. Poindexter | Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| WO2002076464A1 (en) * | 2001-03-22 | 2002-10-03 | Arena Pharmaceuticals, Inc. | Anti-psychosis combination |
| US6956031B2 (en) | 2002-03-27 | 2005-10-18 | Schering Aktiengesellschaft | 11β-Substituted 19-nor-17-α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring |
| DE10226326A1 (de) | 2002-06-11 | 2004-01-15 | Schering Ag | 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene |
| US7414043B2 (en) | 2002-06-11 | 2008-08-19 | Schering Ag | 9-α-substituted estratrienes as selectively active estrogens |
| PL1689410T3 (pl) | 2003-11-26 | 2008-10-31 | Bayer Schering Pharma Ag | Sposób zapobiegania i leczenia nadciśnieniowych chorób serca za pomocą selektywnych estrogenów: 8ß-winylo-estra-1,3,5(10)-trien-3,17ß-diolu i 17ß-fluoro-9a-winylo-estra-1,3,5(10)-trien-3,16a-diolu |
| US20050277625A1 (en) | 2004-05-21 | 2005-12-15 | Ralf Wyrwa | Estriol and estetrol prodrugs |
| DE102004025985A1 (de) | 2004-05-21 | 2005-12-15 | Schering Ag | Estriol- und Estetrol-Prodrugs |
| DE102004025966A1 (de) | 2004-05-21 | 2005-12-15 | Schering Ag | Estradiol-Prodrugs |
| US7534780B2 (en) | 2004-05-21 | 2009-05-19 | Bayer Schering Pharma Aktiengesellschaft | Estradiol prodrugs |
| DE102004025986A1 (de) | 2004-05-21 | 2005-12-15 | Schering Ag | Steroid-Prodrugs mit androgener Wirkung |
| AR053845A1 (es) | 2005-04-15 | 2007-05-23 | Tibotec Pharm Ltd | 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450 |
-
2000
- 2000-05-31 DE DE10027887A patent/DE10027887A1/de not_active Ceased
-
2001
- 2001-05-08 CA CA002410630A patent/CA2410630A1/en not_active Abandoned
- 2001-05-08 DE DE50108674T patent/DE50108674D1/de not_active Expired - Lifetime
- 2001-05-08 JP JP2001587809A patent/JP2003534386A/ja active Pending
- 2001-05-08 CZ CZ2003621A patent/CZ2003621A3/cs unknown
- 2001-05-08 US US10/296,973 patent/US7507725B2/en not_active Expired - Fee Related
- 2001-05-08 EA EA200201201A patent/EA006432B1/ru not_active IP Right Cessation
- 2001-05-08 BR BR0111294-5A patent/BR0111294A/pt not_active Application Discontinuation
- 2001-05-08 YU YU90102A patent/YU90102A/sh unknown
- 2001-05-08 NZ NZ535201A patent/NZ535201A/en unknown
- 2001-05-08 MX MXPA02011844A patent/MXPA02011844A/es active IP Right Grant
- 2001-05-08 ME MEP-146/08A patent/MEP14608A/xx unknown
- 2001-05-08 KR KR1020087009746A patent/KR20080038460A/ko not_active Abandoned
- 2001-05-08 AU AU6593301A patent/AU6593301A/xx active Pending
- 2001-05-08 SK SK291-2003A patent/SK2912003A3/sk not_active Application Discontinuation
- 2001-05-08 AT AT01943329T patent/ATE315407T1/de not_active IP Right Cessation
- 2001-05-08 HR HR20021038A patent/HRP20021038B1/xx not_active IP Right Cessation
- 2001-05-08 ES ES01943329T patent/ES2256256T5/es not_active Expired - Lifetime
- 2001-05-08 KR KR1020027016148A patent/KR20030017524A/ko not_active Ceased
- 2001-05-08 PL PL361426A patent/PL206462B1/pl not_active IP Right Cessation
- 2001-05-08 AU AU2001265933A patent/AU2001265933B2/en not_active Ceased
- 2001-05-08 DK DK01943329T patent/DK1294402T4/da active
- 2001-05-08 EP EP01943329A patent/EP1294402B2/de not_active Expired - Lifetime
- 2001-05-08 WO PCT/EP2001/005169 patent/WO2001091797A2/de not_active Ceased
- 2001-05-08 HU HU0301949A patent/HUP0301949A3/hu unknown
- 2001-05-08 PT PT01943329T patent/PT1294402E/pt unknown
- 2001-05-08 KR KR1020097014971A patent/KR20090090398A/ko not_active Ceased
- 2001-05-08 CN CN01810337A patent/CN1441678A/zh active Pending
- 2001-05-08 IL IL15293201A patent/IL152932A0/xx active IP Right Grant
- 2001-08-05 UA UA20021210409A patent/UA76953C2/uk unknown
-
2002
- 2002-11-19 IL IL152932A patent/IL152932A/en not_active IP Right Cessation
- 2002-11-21 ZA ZA200209490A patent/ZA200209490B/en unknown
- 2002-11-29 NO NO20025739A patent/NO20025739D0/no not_active Application Discontinuation
-
2003
- 2003-02-14 BG BG107556A patent/BG107556A/bg unknown
-
2008
- 2008-06-19 US US12/142,332 patent/US20090023896A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU90102A (sh) | Jedinjenja sa sulfonamidnom grupom i farmaceutski sastavi koji sadrže ova jedinjenja | |
| TR200402656T4 (tr) | Antikanser ajanları olarak faydalı tiyofen türevleri | |
| EP1100522A4 (en) | ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG | |
| DK0781781T3 (da) | Camptothecinderivater | |
| DK1140918T3 (da) | Thrombininhibitorer | |
| BRPI0108395B8 (pt) | derivados de pirrolopirimidinona, processos de preparação e uso | |
| MEP9509A (en) | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof | |
| CY1109457T1 (el) | Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει | |
| TR199903191T2 (xx) | Vorikonazol i�eren ila� form�lasyonlar�. | |
| BR0010938A (pt) | Derivados da 13-metil eritromicina | |
| BR0001468A (pt) | ácidos dioxiciclopentil hidroxânicos | |
| TR200102038T2 (tr) | Amid bileşenler | |
| TR200301723T4 (tr) | 1,3 Dihidro-2H-indol-2 one türevleri ve bunların, arginin-vasopressin' in V1B veya V1B reseptörleri için bağ maddeleri olarak kullanımı | |
| BRPI0518068A (pt) | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada | |
| BR0212069A (pt) | Agentes antidiabéticos orais | |
| ATE84045T1 (de) | Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen. | |
| BR9807506A (pt) | Derivados de amida e composições medicinais dos mesmos | |
| EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций | |
| BR0316307A (pt) | Compostos, processo de preparação dos mesmos, composição farmacêutica e utilização dos compostos | |
| BR0109573A (pt) | Composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo, agente, composição farmacêutica, e, uso de um composto ou uma pró-droga ou um sal farmacologicamente aceitável do mesmo | |
| FR2797446B1 (fr) | Derives de phenanthroline-7-ones et leurs applications en therapeutique | |
| BR0215680A (pt) | Composição farmacêutica oral estável | |
| EE200100196A (et) | a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks | |
| BR9807694A (pt) | de um princìpio ativo | |
| ATE268768T1 (de) | Antithrombosemittel |